The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis;
pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental …

Objectives To develop recommendations for the diagnosis, prevention and treatment of
neuropsychiatric systemic lupus erythematosus (NPSLE) manifestations. Methods The …

The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …

Objectives To assess the prevalence of the main causes of morbi-mortality in the
antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the …

Objective To analyze the clinical and immunologic manifestations of antiphospholipid
syndrome (APS) in a large cohort of patients and to define patterns of disease expression …

Objective: Systemic lupus erythematosus (SLE) is a complex disease with variable
presentations, course and prognosis. We sought to develop evidence-based …

Neuropsychiatric events are common in patients with systemic lupus erythematosus (SLE),
but less than one-third of these events can be directly attributed to SLE. Increased …

Objectives: To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

The Euro-Phospholipid project started in 1999 with a multicentre, consecutive and
prospective design. A total cohort of 1000 patients with antiphospholipid syndrome (APS) …

Objective To systematically review the efficacy and safety data of different therapeutic
approaches in patients with antiphospholipid antibodies (aPL) and thrombosis. Methods The …